Cargando…

Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1–Nrf2 Protein–Protein Interaction

[Image: see text] Upregulation of the transcription factor Nrf2 by inhibition of the interaction with its negative regulator Keap1 constitutes an opportunity for the treatment of disease caused by oxidative stress. We report a structurally unique series of nanomolar Keap1 inhibitors obtained from a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Begnini, Fabio, Geschwindner, Stefan, Johansson, Patrik, Wissler, Lisa, Lewis, Richard J., Danelius, Emma, Luttens, Andreas, Matricon, Pierre, Carlsson, Jens, Lenders, Stijn, König, Beate, Friedel, Anna, Sjö, Peter, Schiesser, Stefan, Kihlberg, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883477/ https://www.ncbi.nlm.nih.gov/pubmed/35108001 http://dx.doi.org/10.1021/acs.jmedchem.1c01975

Ejemplares similares

Correction to “Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1–Nrf2 Protein–Protein Interaction”
por: Begnini, Fabio, et al.
Publicado: (2023)

Mining Natural Products for Macrocycles to Drug Difficult Targets
por: Begnini, Fabio, et al.
Publicado: (2020)

Cell Permeability of Isomeric Macrocycles: Predictions and NMR Studies
por: Begnini, Fabio, et al.
Publicado: (2021)

A cell-active cyclic peptide targeting the Nrf2/Keap1 protein–protein interaction
por: Iegre, Jessica, et al.
Publicado: (2023)

Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?
por: Poongavanam, Vasanthanathan, et al.
Publicado: (2018)

Polymorphic Structure Determination of the Macrocyclic Drug Paritaprevir by MicroED
por: Bu, G, et al.
Publicado: (2023)

Macrocycles in Drug Discovery—Learning from the Past for the Future
por: Garcia Jimenez, Diego, et al.
Publicado: (2023)

MicroED as a powerful tool for structure determination of macrocyclic drug compounds directly from their powder formulations
por: Danelius, E, et al.
Publicado: (2023)

Simulation Reveals the Chameleonic Behavior of Macrocycles
por: Sethio, Daniel, et al.
Publicado: (2022)

Application of Optical Biosensors in Small-Molecule Screening Activities
por: Geschwindner, Stefan, et al.
Publicado: (2012)

How Proteins Bind Macrocycles
por: Villar, Elizabeth A., et al.
Publicado: (2014)

Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors
por: Leung, Chung-Hang, et al.
Publicado: (2019)

Protein Macrocyclization for Tertiary Structure Stabilization
por: Haim, Anissa, et al.
Publicado: (2021)

Facile Fabrication of Protein–Macrocycle Frameworks
por: Ramberg, Kiefer O., et al.
Publicado: (2021)

Structure‐Guided Design of G‐Protein‐Coupled Receptor Polypharmacology
por: Kampen, Stefanie, et al.
Publicado: (2021)

Macrocyclic Peptides Uncover a Novel Binding Mode for Reversible Inhibitors of LSD1
por: Yang, Jie, et al.
Publicado: (2020)

Keap1-Independent Regulation of Nrf2 Activity by Protein Acetylation and a BET Bromodomain Protein
por: Chatterjee, Nirmalya, et al.
Publicado: (2016)

KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
por: Crisman, Enrique, et al.
Publicado: (2022)

Comprehensive Analysis of Loops at Protein-Protein Interfaces for Macrocycle Design
por: Gavenonis, Jason, et al.
Publicado: (2014)

Utilization of macrocyclic peptides to target protein-protein interactions in cancer
por: Yang, Jiawen, et al.
Publicado: (2022)

Trapping an Ester Hydrate Intermediate in a π-Stacked Macrocycle with Multiple Hydrogen Bonds
por: Wang, Bin, et al.
Publicado: (2023)

Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents
por: Abed, Dhulfiqar Ali, et al.
Publicado: (2015)

Modified Peptide Inhibitors of the Keap1–Nrf2 Protein–Protein Interaction Incorporating Unnatural Amino Acids
por: Georgakopoulos, Nikolaos D., et al.
Publicado: (2018)

Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein–Protein Interaction Inhibitors with an Alternative Binding Mode
por: Georgakopoulos, Nikolaos, et al.
Publicado: (2022)

Fragment-based design of selective GPCR ligands guided by free energy simulations
por: Matricon, Pierre, et al.
Publicado: (2021)

A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signaling
por: Bollong, Michael J., et al.
Publicado: (2018)

Osmolytes Modulate Photoactivation of Phytochrome: Probing Protein Hydration
por: Balke, Jens, et al.
Publicado: (2023)

Design, synthesis and evaluation of novel small molecules acting as Keap1-Nrf2 protein-protein interaction inhibitors
por: Sun, Yunfeng, et al.
Publicado: (2022)

A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
por: Sun, Yi, et al.
Publicado: (2023)

Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study
por: Peng, Cheng, et al.
Publicado: (2019)

Development of a steady-state FRET-based assay to identify inhibitors of the Keap1-Nrf2 protein–protein interaction
por: Schaap, Marjolein, et al.
Publicado: (2013)

An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis
por: Lu, Meng-Chen, et al.
Publicado: (2016)

The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response
por: Hussong, M, et al.
Publicado: (2014)

FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding
por: Cheng, Kai-Chun, et al.
Publicado: (2019)

Response of Cytoprotective and Detoxifying Proteins to Vanadate and/or Magnesium in the Rat Liver: The Nrf2-Keap1 System
por: Ścibior, Agnieszka, et al.
Publicado: (2021)

Modulating Protein–Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples
por: González-Muñiz, Rosario, et al.
Publicado: (2021)

The KEAP1–NRF2 System in Cancer
por: Taguchi, Keiko, et al.
Publicado: (2017)

Keap1/Nrf2 Signaling Pathway
por: Sykiotis, Gerasimos P.
Publicado: (2021)

Cyclic and Macrocyclic Peptides as Chemical Tools To Recognise Protein Surfaces and Probe Protein–Protein Interactions
por: Cardote, Teresa A. F., et al.
Publicado: (2015)

Chiral macrocyclic terpyridine complexes
por: Brandl, Thomas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3pcneo9unq06p0vh9ibdtt2tgb